Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
about
Chiral discrimination in platinum anticancer drugs.Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)].Biomarkers of head and neck cancer, tools or a gordian knot?Mitochondrial DNA damage and its consequences for mitochondrial gene expressioncis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsThe role of p53 in cancer drug resistance and targeted chemotherapyCollagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracilMicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Transcription inhibition by platinum-DNA cross-links in live mammalian cells.Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsRecognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?Oxaliplatin: a review in the era of molecularly targeted therapyBRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer.The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypesNovel role of base excision repair in mediating cisplatin cytotoxicity.Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity.MicroRNA-mediated drug resistance in breast cancer.Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatinReplacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.Exploiting base excision repair to improve therapeutic approaches for pancreatic cancerInhibition of DNA Synthesis by a Platinum-Acridine Hybrid Agent Leads to Potent Cell Kill in Non-Small Cell Lung CancerMolecular mechanisms of resistance and toxicity associated with platinating agents.Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapyCellular Recognition and Repair of Monofunctional-Intercalative Platinum--DNA AdductsClinical evaluation of postoperative chemotherapy based on genetic testing in patients with stage IIIA non-small cell lung cancer.Expression of XPG protein in human normal and tumor tissues.Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin.Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.Predictive and prognostic markers in colorectal cancer.Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicityDevelopment of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution.Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.
P2860
Q24812493-C821589B-4365-4026-A794-9EC422C79AFDQ24813746-130D1E4F-F189-4A59-A0F4-874FDB8CEF86Q26784289-F3BB5C51-817F-4454-BE44-B05EF1173F91Q27001150-097744FF-ADFF-46B6-B3C9-56E399107CFFQ27650949-6FEA3BBB-642B-4FEF-AD83-0ED4F4B77DF4Q28072553-A5AD2C7F-AB66-4495-86BD-CE7C6BE45803Q28468348-1E0A1B5D-87D2-4EBA-95D1-DC32F8AE9CDDQ33585094-CFB2F3FE-4AC0-49DF-BBB4-4605E138EBAFQ33882179-E0230A0A-A9F3-4703-9942-643A1B830FCEQ33914993-3D02F5F3-2202-4961-BB23-6D3244D8A931Q34008793-BA6830D7-3069-46CA-A3EE-0A0E97E6284AQ34029578-05D5D607-501C-40F5-820E-3A241958C533Q34205171-7A1CC557-44D4-4BDD-B262-2C9E3F357D2BQ34541434-A8FE57F2-44FD-4864-84E6-8E5185BCFCABQ34621524-05F6897B-BCD6-4CC6-9984-6E3742FDDB25Q34634724-88255BE9-87E3-43D6-8FD2-B4EC81089970Q34800428-7FE023F4-5D16-4DD3-A13B-E664F3AD2F58Q34803055-0046B872-B6DC-4B63-9F65-FF098550CE92Q34842777-0CBF7AED-F51A-4709-AF98-B6715736792FQ35165126-EC326EED-766C-42E3-B17E-C4781C8A5BEBQ35175999-32F629DC-3F5C-4EC4-AB54-22B8D4A75EF2Q35257063-E00EDB02-8321-4B02-9854-66BE637769DEQ35377658-7C6F87F5-2300-40BB-B070-294C3D72F8C3Q35596477-78C3C755-EC34-484F-B78E-B29CFBC35395Q35743145-B1CDB169-E905-4F97-BB36-B1CC46AF8445Q35758048-B691ADD7-C1CC-4D0F-92D8-62ADF8EC34DAQ36070191-C8BAA713-2F9E-42A2-B5F5-B21EB89FF13BQ36107216-9D19C4C8-FDDB-4841-90DF-2EC16615A531Q36460000-7B456F0C-3C9B-4A76-8ED0-ADDE6DF5944FQ36477771-2E8D273E-D658-45C9-8A5A-14AB9C28A18EQ36529982-FBBC3F8F-CBEE-491C-BD3B-9DFEED12A8FFQ36610915-F1188500-42B8-47BF-9CA8-022346FC2F49Q36639784-33EF34BE-BD12-47BC-8A45-A859844FB0B8Q36677787-CEB4C3C3-2066-4463-B3E4-54837790F83EQ37073444-81070CC8-9D34-47E0-BEB8-72CEA06EEC37Q37122036-0994F668-550E-4382-85F1-47FFC2676E18Q37309473-CE624590-45F3-4909-B88B-ADCF5A0E1D99Q37309889-0D0FEAFD-C7ED-4F91-BE04-960600C9B68CQ37346994-C13A8919-0DDA-439E-86CF-D56962BAB9C6Q37553543-DD0862CE-5F03-4E5C-AECB-E372645695C8
P2860
Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Efficient nucleotide excision ...... num intrastrand DNA diadducts.
@en
Efficient nucleotide excision ...... num intrastrand DNA diadducts.
@nl
type
label
Efficient nucleotide excision ...... num intrastrand DNA diadducts.
@en
Efficient nucleotide excision ...... num intrastrand DNA diadducts.
@nl
prefLabel
Efficient nucleotide excision ...... num intrastrand DNA diadducts.
@en
Efficient nucleotide excision ...... num intrastrand DNA diadducts.
@nl
P2093
P1433
P1476
Efficient nucleotide excision ...... inum intrastrand DNA diadducts
@en
P2093
P304
P407
P577
1999-08-01T00:00:00Z